| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CHIMERIX INC | 7,232 | 37,000 | 0.05% | ||
| 2 | SHELL MIDSTREAM PARTNERS L P | 1,445 | 53,000 | 0.07% | ||
| 3 | PTC THERAPEUTICS INC | 8,777 | 57,000 | 0.08% | ||
| 4 | NUSTAR ENERGY LP | 1,588 | 64,000 | 0.09% | ||
| 5 | CELLDEX THERAPEUTICS INC NEW | 17,247 | 65,000 | 0.09% | ||
| 6 | SPECTRA ENERGY PARTNERS LP | 1,449 | 70,000 | 0.10% | ||
| 7 | BIOCRYST PHARMACEUTICALS | 26,246 | 74,000 | 0.10% | ||
| 8 | PUMA BIOTECHNOLOGY | 3,321 | 98,000 | 0.14% | ||
| 9 | ARDELYX INC COM | 12,922 | 100,000 | 0.14% | ||
| 10 | CARA THERAPEUTICS INC | 16,267 | 101,000 | 0.14% | ||
| 11 | ADURO BIOTECH INC | 7,966 | 102,000 | 0.14% | ||
| 12 | PORTOLA PHARMACEUTICALS INC | 5,232 | 107,000 | 0.15% | ||
| 13 | NORTHWEST BIOTHERAPEUTICS | 78,696 | 115,000 | 0.16% | ||
| 14 | VITAE PHARMACEUTICALS INC | 17,530 | 116,000 | 0.16% | ||
| 15 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 7,582 | 120,000 | 0.17% | ||
| 16 | SYNERGY PHARMACEUTICALS DEL | 43,341 | 120,000 | 0.17% | ||
| 17 | NANTKWEST INC COM | 14,563 | 120,000 | 0.17% | ||
| 18 | Sierra Oncology, Inc. | 17,902 | 121,000 | 0.17% | ||
| 19 | TETRAPHASE PHARMACEUTICALS INC COM | 26,478 | 123,000 | 0.17% | ||
| 20 | ONCOMED PHARMACEUTICALS INC COM | 12,369 | 125,000 | 0.17% | ||
| 21 | RELYPSA INC | 9,227 | 125,000 | 0.17% | ||
| 22 | NEWLINK GENETICS CORP COM | 7,029 | 128,000 | 0.18% | ||
| 23 | RADIUS HEALTH INCORPORATED COM NEW | 4,086 | 128,000 | 0.18% | ||
| 24 | SAREPTA THERAPEUTICS INC | 6,770 | 132,000 | 0.18% | ||
| 25 | BELLICUM PHARMACEUTICALS INCORPORATED | 14,202 | 133,000 | 0.18% | ||
| 26 | CEMPRA INC | 8,058 | 141,000 | 0.19% | ||
| 27 | Axovant Sciences LTD | 12,579 | 144,000 | 0.20% | ||
| 28 | IGNYTA INC COM | 21,317 | 144,000 | 0.20% | ||
| 29 | CLOVIS ONCOLOGY INC | 7,526 | 144,000 | 0.20% | ||
| 30 | IDERA PHARMACEUTICALS INCORPORATED COM NEW | 74,038 | 147,000 | 0.20% | ||
| 31 | OPHTHOTECH CORP | 3,510 | 148,000 | 0.20% | ||
| 32 | ONCOTHYREON INC COM N/C EFF 6/ | 116,667 | 148,000 | 0.20% | ||
| 33 | SAGE THERAPEUTICS INC | 4,602 | 148,000 | 0.20% | ||
| 34 | PROTHENA CORP PLC | 3,650 | 150,000 | 0.21% | ||
| 35 | ACCELERON PHARMA INC | 5,756 | 152,000 | 0.21% | ||
| 36 | ULTRAGENYX PHARMACEUTICAL INC COM | 2,404 | 152,000 | 0.21% | ||
| 37 | SPARK THERAPEUTICS INCORPORATED | 5,251 | 155,000 | 0.21% | ||
| 38 | CYTOKINETICS INC | 22,124 | 156,000 | 0.21% | ||
| 39 | MACROGENICS INC | 8,385 | 157,000 | 0.22% | ||
| 40 | NOVAVAX INC COM | 30,787 | 159,000 | 0.22% | ||
| 41 | KARYOPHARM THERAPEUTICS INC COM | 17,923 | 160,000 | 0.22% | ||
| 42 | GERON CORP | 55,936 | 163,000 | 0.22% | ||
| 43 | IMMUNOGEN INC | 19,257 | 164,000 | 0.23% | ||
| 44 | LION BIOTECHNOLOGIES INC COM | 32,352 | 164,000 | 0.23% | ||
| 45 | UNIQURE NV | 14,182 | 168,000 | 0.23% | ||
| 46 | MIRATI THERAPEUTICS INC COM | 7,828 | 168,000 | 0.23% | ||
| 47 | CONCERT PHARMACEUTICALS INCORPORATED | 12,664 | 173,000 | 0.24% | ||
| 48 | FIBROGEN INC | 8,215 | 175,000 | 0.24% | ||
| 49 | SERES THERAPEUTICS INC | 6,580 | 175,000 | 0.24% | ||
| 50 | SANGAMO THERAPEUTICS INCORPORATED | 29,061 | 176,000 | 0.24% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017478, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
